As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean. Associate Professor Shobha Swaminathan is principal investigator at the Rutgers New Jersey Medical School Clinical Research Center and the medical director of Infectious Diseases Practice at University Hospital, and Michael K. Gusmano is a bioethicist and professor of health policy at the Rutgers School of Public Health. To read the full story.
Recent Posts
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
- Rutgers researchers: How Meta turned teen attention into a public health crisis.
- Kids under 5 are grabbing their parents’ vapes and getting sick at record levels, researchers say.
- These N.J. medical schools are among some of the best in the country. See how they rank.
- Estrogen Patch Shortages Are Ongoing—Here’s Where to Find Them and What to Ask Your Doctor.
Categories
- Community (2,497)
- Covid (1,001)
- CTO Events (6)
- News (3,170)
- Pilots (21)